Treatment
Medication clinical trials
We’re tracking 7,446 recruiting studies that include Medication, each written for real people, not researchers, below.
Recruiting studies
- NCT06890234Enrolling by invitation
Monitoring liver grafts with a tiny probe during transplant
This study uses a tiny probe placed in the new liver during transplant surgery to monitor its health in real time. It may help doctors detect problems early and improve recovery after transplant.
Ljubljana, SloveniaAges 18–65 - NCT06101030Recruiting
Breathing exercise with or without a reminder device
This study tests whether a special reminder device helps people do their breathing exercises more often after surgery. You will use a breathing exercise tool (incentive spirometer) with or without a reminder that beeps or flashes to prompt you to use it.
Silver Spring, MarylandAges 18 years+ - NCT07671807Recruiting
Adapted table tennis for people with disabilities
This trial tests if adapted table tennis can help improve fitness and well-being for people with disabilities. If you have a disability identification card and are interested in playing table tennis, you may be able to join.
Kaohsiung City, TaiwanAges 18–75 - NCT07329296Enrolling by invitation
Liver regeneration after living donor transplant study
This study looks at how the donor's liver grows back after donating a part of it for a living donor liver transplant. If you have donated a part of your liver between 2004 and 2026, joining could help doctors learn more about liver healing.
Rotterdam, South HollandAges 18–60 - NCT07415616Enrolling by invitation
Cold vs warm tube feeding and stomach emptying in ICU
This study compares giving liquid food at room temperature (cold) versus body temperature (warm) through a feeding tube to see which helps the stomach empty better in ICU patients. It may help find a way to improve comfort and nutrition for people who need tube feeding.
BursaAges 18 years+ - NCT07310316Recruiting
A trial for variceal bleeding in cavernous transformation of portal vein
This study tests a combined procedure to stop bleeding from enlarged veins in the food pipe (varices) in people with a rare condition called cavernous transformation of the portal vein. The treatment involves blocking the bleeding veins and reducing blood flow to the spleen to prevent future bleeding.
Xi'an, ShaanxiAges 18–75 - NCT06423378Enrolling by invitationPhase 2
Kneebar implant for knee pain and bone marrow lesion
This trial tests a new type of implant (a fiber-reinforced kneebar) for people with knee pain caused by a bone marrow lesion (BML) and osteoarthritis. The goal is to see if it helps relieve pain and improve knee function.
Nashville, TennesseeAges 18–75 - NCT06111729Recruiting
Wristband to help stop nail biting
This study tests a special device that helps you become more aware of when you bite your nails, so you can stop. It may help if you have chronic nail biting and want to break the habit.
New York, New YorkAges 18–95 - NCT06112951Recruiting
ECP treatment for early signs of lung transplant rejection
This trial tests whether a therapy called extracorporeal photopheresis (ECP) can stop early, silent rejection in lung transplant patients. It is for people who have developed donor-specific antibodies but still have normal lung function.
ViennaAges 18 years+ - NCT07724028Enrolling by invitation
Nerve stimulation during robotic prostate surgery
This study tests whether stimulating specific nerves during robotic prostate surgery helps preserve erectile function. If you are scheduled for prostate surgery and have normal erections now, this research may help improve your recovery of erections afterward.
LjubljanaAges 18 years+ - NCT07324525Recruiting
Oral health study for people in palliative care
This survey study explores oral health in people receiving palliative care. By answering a questionnaire, you can help improve care and comfort for patients with serious illness.
Göttingen, GermanyAges 18 years+ - NCT06118437Recruiting
Gastrointestinal cancer screening prediction study
This study aims to build a model to predict your risk of gastrointestinal cancer based on personal risk factors. It involves having both an upper endoscopy (gastroscopy) and a colonoscopy at the same time.
Xi'an, ShaanxiAges 18–80 - NCT07185191Recruiting
Device to treat gum shrinkage and black triangles between teeth
This trial tests a medical device (RDM36) to see if it safely and effectively treats gum shrinkage and black triangles between the front teeth, which can affect your smile.
Brescia, ItalyAges 18 years+ - NCT07408453Recruiting
Stress in pregnancy after assisted reproduction
This study looks at stress levels and well-being in pregnant women who used assisted reproduction (IVF, egg donation) and their partners. It aims to understand how these experiences affect early infant development.
Bergamo, BergamoAges 18 years+ - NCT07723157Recruiting
Cesarean scar healing after first C-section
This study watches how a cesarean scar heals after a first-time C-section done after 26 weeks of pregnancy. It's an observational study—no treatments are tested—just careful tracking to learn more about recovery.
GdanskAges 18 years+ - NCT07327788RecruitingPhase 2
Study of QL1706, bevacizumab, and chemo infusion for liver cancer with portal vein clot
This trial tests a combination of three treatments for people with advanced liver cancer that has spread into the main portal vein. The goal is to see if this therapy can shrink tumors and improve outcomes.
Guangzhou, GuangdongAges 18 years+ - NCT07185061Recruiting
Sound treatment for chronic tinnitus
This study tests whether a special sound-based treatment can help people with chronic tinnitus (ringing in the ears). If your tinnitus has lasted more than six months and you don't have other ear or brain problems, you may be able to join.
Nanjing, JiangsuAges 18 years+ - NCT07330037RecruitingPhase 2
TIL plus immunotherapy for NSCLC without complete response after chemoimmunotherapy
This trial tests a new treatment for people with non-small cell lung cancer (NSCLC) that was removed by surgery but did not completely disappear after pre-surgery chemoimmunotherapy. The treatment combines your own tumor-fighting cells (L-TIL, grown from your tumor) with an immunotherapy drug (tislelizumab) to try to keep the cancer from coming back.
Tianjin, Tianjin MunicipalityAges 17–75 - NCT05329636RecruitingPhase 1/Phase 2
Fecal microbiome transplant after H. pylori antibiotic treatment
This trial tests whether transplanting healthy gut bacteria (from fecal material) can help your recovery and gut health after you take antibiotics to clear H. pylori (a stomach germ). If you qualify, you would start with confirmed H. pylori and then follow the study steps for the transplant.
Tel AvivAges 18–70 - NCT05894694RecruitingPhase 4
Testing Compound Kushen injection for advanced colon cancer survival
This trial studies whether Compound Kushen injection can improve survival in people with advanced colorectal cancer. It’s aimed at people starting first-line treatment, and only includes certain cancer and health situations to keep results clear.
BeijingAges 18 years+ - NCT06463691RecruitingPhase 2
Sonrotoclax, Zanubrutinib, and CD20 Antibody for Untreated Mantle Cell Lymphoma
This trial tests a combination of three drugs—sonrotoclax, zanubrutinib, and a CD20 antibody—as a first treatment for mantle cell lymphoma. It aims to see if this new combination is safe and effective for patients who have not yet received any treatment.
TianjinAges 18 years+ - NCT07040098RecruitingPhase 2
Optimizing immunotherapy with chemo-radiation for rectal cancer
This trial tests combining immunotherapy with standard chemotherapy and radiation before surgery for locally advanced rectal cancer. It aims to see if this approach can improve outcomes for patients whose tumors have certain genetic features (pMMR or MSS).
BeijingAges 18–75 - NCT07185438Recruiting
MRI-guided brain stimulation for teenage depression
This study tests whether a type of brain stimulation called rTMS, guided by an MRI scan, can safely help ease depression symptoms in teenagers. You would continue your regular medication during the study.
ChongqingAges 12–18 - NCT06490068RecruitingPhase 2
LTC004 with toripalimab for immunotherapy-resistant solid tumors
This trial tests a new combination of two drugs (LTC004 and toripalimab) for people with advanced solid tumors that have stopped responding to standard immunotherapy. It aims to see if this combination can help when immunotherapy alone no longer works.
BeijingAges 18–75
Common questions
- Are there clinical trials studying Medication?
- Yes. Clin2 currently lists 7,446 recruiting studies that include Medication, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Medication trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Medication an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Medication or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.